ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1123

Random Urinary Uric Acid/Creatinine Ratio Is Useful in the Estimation of 24-Hour Urine Uric Acid Excretion in Patients with Gout

Sang Tae Choi1, Seong-Jin Moon2 and Eun-Jin Kang3, 1Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea, Republic of (South), 2Internal Medicine, Catholic Kwandong University College of Medicine, Incheon, Korea, Republic of (South), 3Internal Medicine, Busan Medical Center, Busan, Korea, Republic of (South)

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Gout and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Metabolic and Crystal Arthropathies Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Gout is a chronic inflammatory disease resulted from hyperuricemia. The measurement of 24-hour urinary uric acid excretion is frequently used to evaluate disease status and select drugs that lower uric acid level. However, 24-hour urine collection is cumbersome and inconvenient, and sometimes unreliable because of incomplete sampling. Approximately 1 g of creatinine is excreted into the urine on a daily basis, and the ratio of random urine protein to creatinine is known to be closely related to the amount of 24-hour urine protein excretion. Therefore, in this study, we assessed the utility of the random urinary uric acid/creatinine (UA/Cr) ratio in the estimation of 24-hour urine uric acid excretion in patients with gout.

Methods: Eighty-seven patients with gout without any use of uric acid lowering agents were enrolled in this study. The mean age was 49.8 ± 16.8 years old and the male patient was 89.6% (78/87). For the evaluation of uric acid excretion and renal function, patients were collected 24-hour urine. Random urine uric acid and creatinine specimens were gained on the same day of 24-hour urine collection. Chronic kidney disease was defined as a creatinine clearance (CCr) level of less than 60 ml/min/1.73m2 measured in 24-hour urine collection sample. Excretion of more than 650 mg of uric acid in the 24-hour urine sample was defined as uric acid over-excretion.

Results: Mean serum uric acid level was 7.77 ± 1.92 mg/dl, and the mean 24-hour uric acid excretion and mean CCr value were 669.6 ± 237.9 mg and 109.6 ± 39.0 ml/min/1.73m2,, respectively. Random urinary UA/Cr ratio showed good correlation with the 24-hour urine uric acid excretion in the absolute and log-transformed value (γ = 0.413, p < 0.001; γ = 0.585, p <0.001, respectively). Correlation between these two variables was also found in the patients with chronic kidney disease (γ = 0.789, p = 0.011). In the linear regression analysis, absolute 24-hour urine uric acid excretion was estimated to be 402 x (random urinary UA/Cr ratio) + 218.73 (p < 0.001). The best cut-off value for the random urinary UA/Cr ratio to distinguish between uric acid over-excretion and normal uric acid excretion was 0.533, and its sensitivity and specificity were 35.6% and 97.6%, respectively (AUC = 0.686; 95% CI, 0.576 – 0.796, p = 0.003).

Conclusion: There was a good correlation between the random urinary UA/Cr ratio and 24-hour urine uric acid excretions. The random urinary UA/Cr ratio would be a useful predictor of 24-hour urine uric acid excretion in patients with gout.


Disclosure: S. T. Choi, None; S. J. Moon, None; E. J. Kang, None.

To cite this abstract in AMA style:

Choi ST, Moon SJ, Kang EJ. Random Urinary Uric Acid/Creatinine Ratio Is Useful in the Estimation of 24-Hour Urine Uric Acid Excretion in Patients with Gout [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/random-urinary-uric-acidcreatinine-ratio-is-useful-in-the-estimation-of-24-hour-urine-uric-acid-excretion-in-patients-with-gout/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/random-urinary-uric-acidcreatinine-ratio-is-useful-in-the-estimation-of-24-hour-urine-uric-acid-excretion-in-patients-with-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology